EGFR and metabolic dysfunction-associated steatohepatitis: Together, our studies pointed to betacellulin (BTC), one of several epidermal growth factor receptor (EGFR) agonists, as a master regulatory molecule that was downregulated by ω3 PUFA in the NASH liver.